Aurobindo Pharma to Buy Solar Power From Open Access Projects in Telangana

The company will invest ₹107.6 million to acquire 26% capital shares in two open access power projects

February 24, 2021

/ Harsh Shukla
/ Finance and M&A, Solar
thumbnail

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights


Aurobindo Pharma, a Hyderabad-based pharmaceutical company, will procure solar power from two 15 MW group captive projects of NVNR Power and Infra in Hyderabad, Telangana.

MERCOM Insider

Where clean energy's most influential leaders get their intelligence

Exclusive reporting, market intelligence, and insider access that shapes billion-dollar decisions in renewable energy and clean technology.

Already have an account? Sign In

Register for free

thumbnail

Harsh Shukla

More articles from Harsh Shukla.
Aurobindo PharmainvestmentNVNRPowerSolar
PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

RECENT POSTS